Loading
No insider purchase over the last 90 days. The latest, by Seghezzi Graziano, was filed 18 Apr 2013.
This page follows insider dealings at Omthera Pharmaceuticals, Inc. as filed with SEC (Form 4). No insider at Omthera Pharmaceuticals, Inc. has published a filing in the past twelve months. The most recent one dates from 18 July 2013.
Over the whole record (from 2013), the tally stands at 2 purchases and 3 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
25 of 54 declarations
Omthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for metabolic diseases. It is listed on NASDAQ under the ticker OMTH.